1. Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells. Issue 3 (17th March 2022) Authors: Beyer, Mandy; Henninger, Sven J.; Haehnel, Patricia S.; Mustafa, Al-Hassan M.; Gurdal, Ece; Schubert, Bastian; Christmann, Markus; Sellmer, Andreas; Mahboobi, Siavosh; Drube, Sebastian; Sippl, Wolfgang; Kindler, Thomas; Krämer, Oliver H. Journal: Cell chemical biology Issue: Volume 29:Issue 3(2022) Page Start: 398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗